株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インドにおける糖尿病市場

Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

発行 IMARC Services Private Limited 商品コード 345916
出版日 ページ情報 英文 108 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.60円で換算しております。
Back to Top
インドにおける糖尿病市場 Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics
出版日: 2019年06月10日 ページ情報: 英文 108 Pages
概要

当レポートでは、インドにおける糖尿病市場について調査し、糖尿病有病率や人口統計学的特徴、診断や治療法、治療薬、その効果や売上などを検証・分析するほか、主要企業のプロファイルや競合情勢などをまとめています。

第1章 序論

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 糖尿病の概要

  • 糖尿病について
  • 診断・治療法
  • 糖尿病の合併症

第5章 インドの糖尿病市場の成長要因

第6章 インドにおける糖尿病の疫学

  • 糖尿病人口と有病率
  • 糖尿病人口と有病率:糖尿病の種類別(Type1、2)
  • 糖尿病人口と有病率:地域別(都市、地方)
  • 糖尿病人口と有病率:性別
  • 糖尿病人口と有病率:年代別
  • 糖尿病診断と薬物治療を受ける患者の割合

第7章 インドの糖尿病市場

  • 過去の市場動向
  • 市場内訳:セグメント別
  • インドの経口血糖投下薬市場
    • 市場動向
    • 市場内訳:薬物クラス別
    • 主要企業の市場シェア
    • 市場展望
  • 今後の市場展望

第8章 インドの糖尿病診断市場

  • 市場動向
  • 市場区分
  • 主要企業の市場シェア
  • 市場展望

第9章 SWOT分析

  • 強味
  • 弱味
  • 機会
  • 脅威

第10章 バリューチェーン分析

第11章 ファイブフォース分析

第12章 競合構造

第13章 主要企業のプロファイル

図表

List of Figures

Figure 4-1: The Impact of Diabetes on the Human Body

Figure 4-2: Diabetes Complications

Figure 4-3: India: Overweight & Obese Population (in Million), 2011, 2018 & 2024

Figure 5-2: Body Mass Index and Relative Risk of Type-2 Diabetes

Figure 5-3: Global: Breakup of Diabetes Patients by Region (in %), 2018 & 2024

Figure 6-1: India: Total Number of Diabetes Patients (in Millions), 2011-2018

Figure 6-2: India: Total Number of Diabetes Patients Forecast (in Millions), 2019 - 2024

Figure 6-3: India (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2011-2018

Figure 6-4: India (Type1 & Type2): Total Number of Diabetes Patients Forecast (in Millions) 2019 - 2024

Figure 6-5: India (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2011-2018

Figure 6-6: India (Urban & Rural): Total Number of Diabetes Patients Forecast (in Millions), 2019 - 2024

Figure 6-7: India (Male & Female): Total Number of Diabetes Patients (in Millions), 2011-2018

Figure 6-8: India (Male & Female): Total Number of Diabetes Patients Forecast (in Millions), 2019 - 2024

Figure 6-9: India: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79-in Million), 2011 - 2018

Figure 6-10: India: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79-in Million), 2019 - 2024

Figure 6-11: India: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2011-2018

Figure 6-12: India: Total Diagnosed & Drug Treated Diabetes Population Forecast (in Millions), 2019 - 2024

Figure 7-1: India: Diabetes Market (in Million US$), 2011-2018

Figure 7-2: India: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2011-2018

Figure 7-3: India: Oral Antidiabetics Market (in Million US$), 2011-2018

Figure 7-4: India: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2011-2018

Figure 7-5: India: Oral Antidiabetics Market: Sales Share of Key Players (in %)

Figure 7-6: India: Oral Antidiabetics Market Forecast (in Million US$), 2019 - 2024

Figure 7-7: India: Insulin Market (in Million US$), 2011-2018

Figure 7-8: India: Insulin Market: Sales Share of Key Classes (in %)

Figure 7-9: India: Insulin Market: Sales Share of Key Players (in %)

Figure 7-10: India: Insulin Market Forecast (in Million US$), 2019 - 2024

Figure 7-11: India: Diabetes Market Forecast (in Million US$), 2019 - 2024

Figure 7-12: India: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2019 - 2024

Figure 8-1: India: Glucose Monitoring Market (in Million US$), 2011-2018

Figure 8-2: India: Glucose Monitoring Market: Sales Share by Segment (in %)

Figure 8-3: India: Glucose Monitoring Market: Sales Share of Key Players (in %)

Figure 8-4: India: Glucose Monitoring Market Forecast (in Million US$), 2019 - 2024

Figure 9-1: Indian: Diabetes Market: SWOT Analysis

Figure 10-1: Indian: Diabetes Market: Value Chain Analysis

Figure 11-1: Indian: Diabetes Market: Porter's Five Forces Analysis

List of Tables

Table 2-1: India: Diabetes Market: Industry Overview

Table 3-1: Diagnosis of Diabetes

Table 4-1: India: Overweight & Obesity Statistics, 2005, 2010 & 2018

Table 4-2: India: Urban & Rural Population Breakup (in Million), 1992, 2001, 2011

Table 4-3: Global: Diabetes Population Breakup by Country (in 000's), 2018 & 2024

Table 4-4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets

Table 5-1: India: Total Prevalence & Number of Diabetes Patients (in Million), 2011, 2018 & 2024

Table 5-2: India (Type1 & Type2): Total Prevalence & Number of Diabetes Patients (in Million), 2011, 2018 & 2024

Table 5-3: India (Urban & Rural): Total Prevalence & Number of Diabetes Patients (in Million), 2011, 2018 & 2024

Table 5-4: India (Male & Female): Total Prevalence & Number of Diabetes Patients (in Million), 2011, 2018 & 2024

Table 5-5: Total Prevalence & Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79- in Million), 2011, 2018 & 2024

Table 5-6: India: Total Diagnosed & Drug Treated Diabetes Population (in Million), 2011, 2018 & 2024

Table 7-1: India: Diabetes Market: Key Industry Highlights 2018 and 2024

目次
Product Code: SR1019C11_Report

The Indian diabetes market reached a value of US$ 1,954 Million in 2018. The market is further expected to grow at a CAGR of 16.7% during 2019-2024. Diabetes is rapidly gaining the status of a potential epidemic in India with around 65 million people currently being affected by it. The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable to diabetes compared to other population groups, India's struggle with diabetes is expected to be one of the biggest epidemics the country has ever witnessed.

India's diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in the healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.

IMARC's new report "Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics" provides an analytical and statistical insight into the Indian diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments - Oral Antidiabetics, Insulin and Diabetes Diagnostics. For each of the aforementioned categories, the report provides historical and future market sales, performance of key classes and the performance of top players.

The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Indian diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian diabetes market in some form or the other.

What we have achieved in this report:

Comprehensive situation analysis of the Indian diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in India
  • Historical, current and future prevalence of type-1 and type-2 diabetes in India
  • Historical, current and future prevalence of diabetes in the urban and rural regions in India
  • Historical, current and future prevalence of diabetes among males and females in India
  • Historical, current and future prevalence of diabetes among various age groups in India
  • Historical, current and future diagnosis rates for diabetes in India
  • Historical, current and future drug treatment rates for diabetes in India

Comprehensive situation analysis of the Indian Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the Indian Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the diabetes diagnostics market and its dynamics:

Focus of the Analysis:

  • Performance of the diabetes diagnostics market in India
  • Performance of key classes
  • Performance of key players
  • Market outlook

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Diabetes Disease Overview

  • 4.1 What is Diabetes?
  • 4.2 Diabetes Diagnosis and Treatment
    • 4.2.1 Diagnosis
    • 4.2.2 Treatment
  • 4.3 Diabetes Complications

5 Factors Driving the Diabetes Market in India

  • 5.1 Increasing Obesity Levels
  • 5.2 Urbanization
  • 5.3 India has the Second Largest Diabetes Patient Base in the World
  • 5.4 India Represents One of the Fastest Growing Markets Globally
  • 5.5 Improving Diagnosis and Treatment Rates

6 The Indian Diabetes Epidemiology

  • 6.1 Diabetes Population and Prevalence Rates
  • 6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
  • 6.3 Population and Prevalence Rates by Region (Urban and Rural)
  • 6.4 Population and Prevalence Rates by Gender
  • 6.5 Population and Prevalence Rates by Age Group
  • 6.6 Diabetes Diagnosis and Drug Treatment Rates

7 Indian Diabetes Market

  • 7.1 Historical Market Trends (2011-2018)
  • 7.2 Market Breakup by Segment (2011-2018)
  • 7.3 Indian Oral Antidiabetics Market
    • 7.3.1 Historical Market Trends (2011-2018)
    • 7.3.2 Market Breakup by Class (2011-2018)
    • 7.3.3 Market Shares of Key Players
    • 7.3.4 Market Outlook (2019 - 2024)
  • 7.4 Indian Insulin Market
    • 7.4.1 Historical Market Trends (2019 - 2024)
    • 7.4.2 Market Breakup by Class
    • 7.4.3 Market Shares of Key Players
    • 7.4.4 Market Outlook (2019 - 2024)
  • 7.5 Market Outlook (2019 - 2024)

8 Indian Diabetes Diagnostics Market

  • 8.1 Historical Market Trends (2011-2018)
  • 8.2 Market Breakup by Product Type
  • 8.3 Key Players
  • 8.4 Market Outlook (2019 - 2024)

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porter's Five Forces

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.5 Threat of New Entrants

12 Competitive Landscape

  • 12.1 Competitive Structure
  • 12.2 Key Player Profiles
Back to Top